Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging

SIMPLE SUMMARY: Pancreatic cancer remains one of the most lethal tumor entities worldwide given its overall 5-year survival after diagnosis of 9%. Thus, further understanding of molecular changes to improve individual prognostic assessment as well as diagnostic and therapeutic advancement is crucial...

Descripción completa

Detalles Bibliográficos
Autores principales: Loch, Florian N., Klein, Oliver, Beyer, Katharina, Klauschen, Frederick, Schineis, Christian, Lauscher, Johannes C., Margonis, Georgios A., Degro, Claudius E., Rayya, Wael, Kamphues, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533220/
https://www.ncbi.nlm.nih.gov/pubmed/34681132
http://dx.doi.org/10.3390/biology10101033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533220/
https://www.ncbi.nlm.nih.gov/pubmed/34681132
http://dx.doi.org/10.3390/biology10101033

Ejemplares similares